Jeffrey Berkowitz, CEO and Director

Mr. Berkowitz is one of the rare top executives whose career has spanned most key verticals in global healthcare — with executive committee and other senior roles at United Health Group, Walgreens Boots Alliance (formerly Walgreens), Merck and Schering-Plough.

He joined RE from UnitedHealth Group/Optum where he led Optum’s International division as CEO while also driving key strategic initiatives within Optum’s pharmacy benefits management division. Prior to joining United, Mr. Berkowitz served as President of Pharma and Global Market Access at the Walgreens Boots Alliance, responsible for generic and branded procurement, inventory management, relationships with pharmaceutical companies as well as the companies pricing and reimbursement strategies with all payors and payor segments. Mr. Berkowitz also had responsibility for the specialty pharmacy business with over $10 billion in revenue and 5,800 employees.

Mr. Berkowitz joined Walgreens from Merck & Co., where, as SVP of global market access, he was accountable for all access, pricing, payer marketing, health outcomes and health technology assessments worldwide. Mr. Berkowitz had held a similar position at Schering-Plough, where he started as legal director for Schering-Plough’s managed care and commercial group in 1998. Before joining Schering, Mr. Berkowitz was a healthcare attorney for the international law firm Proskauer LLP in New York and Washington, D.C.

Mr. Berkowitz earned his bachelor’s degree in political science from Union College in Schenectady, N.Y., and his Juris Doctor from Brooklyn Law School in Brooklyn, N.Y. He has been recognized three times in PharmaVoice magazine as one of the 100 Most Inspiring Leaders in the Life Sciences in 2009, 2010 and 2012 and is the recipient of PharmaVoice’s inaugural Red Jacket recognition.

Mr. Berkowitz serves on the board of directors of H. Lundbeck A/S, Esperion Therapeutics, Inc., and Zealand Pharmaceuticals, Inc. Berkowitz also serves as an Editorial Advisor to Life Science Leader and Pharmaceutical Commerce magazines and served on the Board of Directors of the Swiss-American Chamber of Commerce.

Our Team

Jeffrey Berkowitz

CEO and Director

Mr. Berkowitz is one of the rare top executives whose career has spanned most key verticals in global healthcare -- with executive committee and....

read full biography >

Susan Raiola

President

Susan Raiola is the President of Real Endpoints. Ms. Raiola has over 10 years of experience in the pharmaceutical consulting...

read full biography >

Roger Longman

Founder and Chairman

Roger Longman is co-founder and chairman of Real Endpoints LLC, a leading reimbursement-focused.....

read full biography >

Jane F. Barlow, MD, MPH, MBA

EVP & Chief Clinical Officer

Jane Barlow is a clinical and strategic executive with over 25 years of healthcare leadership...

read full biography >

Ryan Walsh

Vice President, Client Services

Ryan Walsh joins Real Endpoints as Vice President for Client Services.  In this capacity, Ryan is responsible for marketing and promotional.....

read full biography >

Rob O’Brien

Vice President, Specialty

Rob O’Brien, RE’s VP Specialty, has over 20 years of managed care, PBM, and specialty pharmacy experience. Over the past

read full biography >

Beth Nash, MD

Chief Medical Officer

Dr. Beth Nash is Chief Medical Officer at Real Endpoints, where her team of pharmacists and biostatisticians has developed...

read full biography >

Amy Steinkellner, PharmD

Senior Consultant

Amy Steinkellner, PharmD, has worked with the Real Endpoint team since 2012. She serves as senior clinical advisor to the research...

read full biography >

Jeffrey Berkowitz

CEO and Director

Mr. Berkowitz is one of the rare top executives whose career has spanned most key verticals in global healthcare —

read full biography >

Linda Blackerby

Linda has been serving as the President of Pharma Intelligence at Informa since May 2015, overseeing an income statement...

read full biography >

Robert Galvin, MD

Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms...

read full biography >

Roger Longman

Founder and Chairman

Mr. Longman is recognized as an expert in biopharmaceutical strategy and reimbursement and often speaks at key industry events organized

read full biography >

Arthur Pappas (Observer)

Art has over 30 years of experience as a pharmaceutical industry executive and venture capital investor in...

read full biography >

Dennis Purcell

Dennis is the Founder, Senior Advisor, and previous Senior Managing Partner of Aisling Capital LLC.,  a leading investment firm...

read full biography >

Norman C. Selby

Vice Chairman

Norman C. Selby has spent 35 years in the healthcare world in a variety of consulting, managerial, investor and Board

read full biography >

Michael Sherman, MD

Dr. Michael Sherman serves as Chief Medical Officer and senior vice president for Harvard Pilgrim Health Care...

read full biography >